Loading company…
Metaphore Biotechnologies uses computational methods to design therapeutics.
Metaphore's MIMiC platform combines machine learning and molecular mimicry to design therapeutic compounds. The company is developing treatments for conditions including autoimmune, metabolic and oncology indications. Founded in 2021, it is based in Cambridge, US. It raised undisclosed venture funding from Lotte Holdings CVC in August 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in